NCT07155408Completed
Topical Rifamycin SV for Wound Healing After Sapphire FUE Hair Transplantation
Topical Rifamycin SV After Sapphire FUE: Accelerated Wound Healing and Anticipatory and Preventive Nursing Care
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Elif Asena KANTARCI
- Participants (registry)
- 70
- Start
- December 2021
- Primary completion
- May 2022
- Study completion
- June 2022
- Last registry update
- September 2026
- Countries
- Turkey
Conditions studied: Androgenetic Alopecia, Wound Healing
Interventions: Povidone-Iodine 10%, Rifamycin SV Sodium, RIF 125 mg/1.5 mL
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.